Interventional Cardiology Devices Market 2016: Major Steps Involved in the Production and Distribution Of Value chain Analysis

Coronary artery bypass surgery (CABG) was invented 50 years ago for the treatment of complex ischemia and multi-vessel coronary artery disease (CAD). However, CABG procedures (according to the studies conducted by the NCBI) is witnessing decline due to evolution of interventional techniques. Interventional cardiology is a minimally invasive catheter based technology that enables treatment of coronary artery disease.

Minimally invasive surgeries have advantages such as shorter hospital stay, reduced cost, minimal incision, less post-surgical complications and shorter recovery time. Geriatric population and rising prevalence of coronary artery diseases are the prime reasons driving the growth of global interventional cardiology. Rising prevalence of lifestyle habits such as smoking, rising incidence of obesity, and dietary irregularities are responsible for the growth of cardiac artery disease prevalence in the world. In Europe, CAD accounts for 1.9 million deaths each year. Moreover, 1 individual in 5 (21% men, 22% women) dies from coronary artery disease in the Europe.

Get Free Report Brochure With Industry Insight:http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=853

The global interventional cardiology devices market has been estimated based on various device types: stents, catheters, percutaneous transluminal coronary angioplasty (PTCA) balloons, percutaneous transluminal coronary angioplasty (PTCA) guide wires, and other accessories. The stents segment held the largest share of the market in 2013 which is further subdivided into bare metal stents, drug eluting stents and bio-absorbable vascular stents. Coronary stents are used for variety of coronary artery diseases including bifurcation lesions, small lesions and narrow lesions.

Coronary stents have improved the clinical outcome for all the approved indications and quality life of patients. Drug eluting stents accounted for the largest market share of the overall interventional cardiology devices market in 2014 and continues to be the leader during the forecast period. The leadership of DES segment was primarily attributed to improved patient outcome as compared to bare metal stents and reduced need for repeated interventions. Rising prevalence of coronary artery disease and requirement of effective therapies for the reducing the rate of restenosis would also fuel the market growth.

Percutaneous transluminal coronary angioplasty (PTCA) balloons have been subdivided into normal balloons, cutting balloons, scoring balloons, and drug eluting balloons. Normal balloons accounted for the largest share of PTCA balloons market and would continue to dominate the market during the forecast period as well. The growth of this segment has been attributed to the increasing volume of stents in emerging countries and first mover advantage as compared to other types of balloons. The imaging systems interventional cardiology devices market is further categorized into intravascular ultrasound (IVUS) systems, fractional flow reserve (FFR) systems, and optical coherence tomography (OCT) systems.

Intravascular ultrasound (IVUS) imaging system held majority share of the market in 2013. IVUS has emerged as an effective diagnostic tool over traditional angiography for the diagnosis of atherosclerosis. The system provides detailed cross sectional view of coronary artery and also enables optimal choice of appropriate angioplasty technique for better deployment of stents.

Browse Full Report@ http://www.transparencymarketresearch.com/interventional-cardiology-devices.html

About Us:-
Transparency Market Research is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Contact Us:-
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com

This release was published on openPR.